STELARA J Code: J3357

Self-Administered Drug Exclusion 7 Medicare Administrative Contractors list J3357 as usually self-administered and exclude it from Part B coverage in their jurisdictions. Check the article for your MAC before billing: CGS, First Coast, Noridian (A53032), Noridian (A53033), Novitas, Palmetto, Wellpoint Federal, WPS · All SAD lists →

Drug & Product Overview

HCPCS Descriptor Ustekinumab, for subcutaneous injection, 1 mg

HCPCS Added Date January 1, 2011

Manufacturer Janssen

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About STELARA

Stelara is a medication aligned to the HCPCS J Code: J3357 for billing, pricing, and reimbursement purposes in the United States. This Immunology: Anti-TNF medication is administered via the subcutaneous route and manufactured by Janssen.

According to CMS Drug Use Information: Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis. This monograph is about the following ustekinumab products: ustekinumab, ustekinumab-aauz, ustekinumab-aekn, ustekinumab-auub, ustekinumab-hmny, ustekinumab-kfce, ustekinumab-srlf, ustekinumab-stba, ustekinumab-ttwe.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

6 NDC packages are crosswalked to J3357. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	STELARA
	STELARA
	STELARA
	STELARA

Login to view 6 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

STELARA Pricing & Reimbursement

J3357 Private Payer Reimbursement

$284.48 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Biosimilar Information

STELARA Approval Date: September 25, 2009

Product Name	HCPCS Code	Active Ingredient	BLA Type
STELARA	J3357	Ustekinumab	351(a) Originator Product
STARJEMZA	N/A	Ustekinumab	351(K) Interchangeable
IMULDOSA	Q5098	Ustekinumab	351(K) Biosimilar
STEQEYMA	Q5099	Ustekinumab	351(K) Interchangeable
YESINTEK	Q5100	Ustekinumab	351(K) Interchangeable
WEZLANA	Q5137	Ustekinumab	351(K) Interchangeable
WEZLANA	Q5138	Ustekinumab	351(K) Interchangeable
PYZCHIVA	Q9996	Ustekinumab	351(K) Interchangeable
PYZCHIVA	Q9997	Ustekinumab	351(K) Interchangeable
SELARSDI	Q9998	Ustekinumab	351(K) Interchangeable
SELARSDI	Q9998	Ustekinumab	351(K) Interchangeable
OTULFI	Q9999	Ustekinumab	351(K) Interchangeable

STELARA CPT Administration Codes

CPT Code	Description
96372	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular

JW / JZ modifiers apply

CMS has identified Stelara (J3357) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

STELARA Medically Unlikely Edits (MUE)

The most billing units of J3357 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

90 units / day

= 90 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

STELARA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Crohn's Disease Plaque Psoriasis Psoriatic Arthritis Ulcerative Colitis

Drug Class

Interleukin-12 Antagonist [EPC]Interleukin-12 Antagonists [MoA]Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonists [MoA]

Frequently Asked Questions

Is there an available Stelara billing and coding guide?

Billing and coding information for STELARA can be found through Janssen. Visit Here →

Are there any available Stelara patient assistance programs?

STELARA patient assistance information can be found through Janssen. Visit Here →

Where can I find Stelara prescribing information?

STELARA prescribing information can be found at the link below: Visit Here →

Where can I find Stelara side effect information?

Information regarding STELARA's side effects can be found at MedlinePlus Visit Here →

Does billing STELARA require JZ/JW wastage modifiers?

CMS has identified STELARA(J3357) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.